August 16th, 2008
While the data about exercise helping reduce risk of cancer has been out for a while, the idea that exercise can help during cancer treatment is gaining more and more traction. In fact, some gyms are tailoring their offerings specifically to people living with cancer and experiencing effects of treatment such as lymphedema and cancer-related […]
By Jen -- 0 comments
July 31st, 2008
The Food and Drug Administration has ordered pharmaceutical giant Amgen to revise labels on its growth factor products, which stimulate the production of blood cells and are used in patients with low blood counts undergoing treatment for diseases such as kidney disease and cancer. Some data released in the past year has shown that these […]
By Jen -- 0 comments
July 30th, 2008
As a researcher and strategist in oncology, I’m always excited to hear topics that I discuss every day come up on the news for public discussion. Last night was one example when I heard this fantastic segment on WHYY radio as part of the Radio Times program about the high cost of chemotherapy drugs. (Audio […]
By Jen -- 0 comments
July 8th, 2008
The WSJ reports that patients aren’t the only ones stung by pricesfor Avastin and other expensive cancer drugs. Physicians are also getting burnt. While most drugs are prescribed directly to patients and picked up at a pharmacy, leaving the patient and/or insurance company with the bill (and the pharmacy with the overhead), most cancer drugs […]
By Jen -- 2 comments
July 7th, 2008
The NYT reported this weekend on something that’s been bugging all of us in the oncology world for quite some time. How much should we pay for drugs that seem to slow down cancer’s advance, but that don’t prolong the life of a patient? Some of these drugs lengthen “progression free survival” or other markers […]
By Jen -- 0 comments
Recent Comments